Medicines guidance for healthcare professionals



The WMIC produces medicines-related guidance for healthcare professionals across NHS Wales.

These pages are currently under development and we would welcome feedback on them.



Understanding ranibizumab biosimilar: Ongavia®

Information is provided to support the introduction of Ongavia®▼(ranibizumab) biosimilar by  healthcare professionals involved in the procurement, storage, supply and administration of Ongavia®▼such as Ophthalmology medical and nursing specialists, and pharmacy teams.

Change history

18 Jul 22            Published.